Last Updated: November 8, 2026

Sun Pharma Canada Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARMA CANADA

SUN PHARMA CANADA has one hundred and forty-one approved drugs.

There are three US patents protecting SUN PHARMA CANADA drugs.

Summary for Sun Pharma Canada

US Patents:	3
Tradenames:	65
Ingredients:	61
NDAs:	141

Drugs and US Patents for Sun Pharma Canada

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharma Canada	TERCONAZOLE	terconazole	CREAM;VAGINAL	075953-001	Apr 6, 2004	BX	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Sun Pharma Canada	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OINTMENT;TOPICAL	040041-001	Sep 15, 1994		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Sun Pharma Canada	HALOBETASOL PROPIONATE	halobetasol propionate	CREAM;TOPICAL	077227-001	Aug 4, 2005		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Sun Pharma Canada	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	CREAM;TOPICAL	087102-001	Apr 27, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Sun Pharma Canada

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharma Canada	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	6,399,079	⤷ Start Trial
Sun Pharma Canada	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,399,079	⤷ Start Trial
Sun Pharma Canada	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	5,990,100	⤷ Start Trial
Sun Pharma Canada	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,656,482	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for SUN PHARMA CANADA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Spray	0.25%	➤ Subscribe	2013-12-18

International Patents for Sun Pharma Canada Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2006130510	⤷ Start Trial
European Patent Office	2630951	⤷ Start Trial
European Patent Office	1888026	⤷ Start Trial
Canada	2616112	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Sun Pharma Canada Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2233112	132014902285293	Italy	⤷ Start Trial	PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504
1304992	PA2013025,C1304992	Lithuania	⤷ Start Trial	PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1458369	SPC/GB10/005	United Kingdom	⤷ Start Trial	PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
0347066	42/2002	Austria	⤷ Start Trial	PRODUCT NAME: ESCITALOPRAM UND DESSEN NICHT-TOXISCHE SAEUREADDITIONSSALZE; NAT. REGISTRATION NO/DATE: 1-24549, 1-24550, 1-24551, 1-24552 20020618; FIRST REGISTRATION: SE 17084, 17085, 17086,17087 20011207
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.